HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy
Lung‐Yi Mak, Gavin Cloherty, Danny Ka‐Ho Wong, Jeffrey Gersch, Wai‐Kay Seto, James Fung, Man‐Fung Yuen – 6 November 2020
Table of contents
6 November 2020
Contrast‐Enhanced Ultrasonography–Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure
Hidekatsu Kuroda, Tamami Abe, Yudai Fujiwara, Tomoaki Nagasawa, Yuji Suzuki, Keisuke Kakisaka, Yasuhiro Takikawa – 5 November 2020
Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB
Maximilian Wübbolding, Juan Carlos Lopez Alfonso, Chun‐Yen Lin, Sebastian Binder, Christine Falk, Jennifer Debarry, Paul Gineste, Anke R.M.
Use of Blood Products and Drugs Before Procedures in Patients With Cirrhosis
Achintya D. Singh, Shalimar – 5 November 2020
Current Concepts in Coagulation Profile in Cirrhosis and Acute‐on‐Chronic Liver Failure
Madhumita Premkumar, Shiv Kumar Sarin – 5 November 2020
Addressing Social Determinants of Liver Disease During the COVID‐19 Pandemic and Beyond: A Call to Action
Ani Kardashian, Julius Wilder, Norah A. Terrault, Jennifer C. Price – 4 November 2020 – The COVID‐19 pandemic has exposed healthcare inequities in the USA and highlighted the importance of social conditions in shaping the health of persons. In the field of hepatology, social determinants of health (SDOH) are closely linked to disparities in liver disease prevalence, outcomes, and access to treatment.
Assessment of Noninvasive Markers of Liver Fibrosis in Patients With Chronic Hepatitis C in Ethiopia
Hailemichael Desalegn, Yemisrach Chanie, Paulos Shume, Miftah Delil, Neil Gupta, Asgeir Johannessen – 3 November 2020
Portal and Mesenteric Venous Thrombosis
Sudha Kodali, Ashwani K. Singal – 3 November 2020
Thromboelastography and Utility in Hepatology Practice
Abhishek Shenoy, Nicolas M. Intagliata – 3 November 2020